Bone metastases: Pathogenesis, treatment, and rationale for use of resorption inhibitors
- 23 February 1987
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 82 (2) , 6-28
- https://doi.org/10.1016/0002-9343(87)90483-9
Abstract
No abstract availableKeywords
This publication has 186 references indexed in Scilit:
- Involutional OsteoporosisNew England Journal of Medicine, 1986
- Carbonic Anhydrase II Deficiency in 12 Families with the Autosomal Recessive Syndrome of Osteopetrosis with Renal Tubular Acidosis and Cerebral CalcificationNew England Journal of Medicine, 1985
- The Treatment of Cancer PainNew England Journal of Medicine, 1985
- The Will Rogers PhenomenonNew England Journal of Medicine, 1985
- Regulation of Bone FormationNew England Journal of Medicine, 1983
- Regulation of Bone FormationNew England Journal of Medicine, 1983
- Use of Dichloromethylene Diphosphonate in Metastatic Bone DiseaseNew England Journal of Medicine, 1983
- Bone resorptive factor produced by osteosarcoma cells with osteoblastic features is PGE2Biochemical and Biophysical Research Communications, 1981
- ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESISThe Journal of Experimental Medicine, 1971
- THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST.The Lancet, 1889